Donaco International Limited (ASX:DNA) notes that Vincent Pirina and Mitchell Mansfield have been appointed as joint and several receivers of approximately 224 million shares in the Company.
Donaco International Limited (ASX:DNA) has announced its results for the 6 months ended 31 December 2018 (H1 FY19).
Donaco In ternational Limited (ASX:DNA) provides the following trading update for the three month period ending December 2018.
Collaborate Corporation Limited (ASX:CL8) confirms that it has issued the following fully paid ordinary shares under the controlled placement deed with Acuity Capital.
Collaborate Corporation Limited (ASX:CL8) is pleased to announce the execution of a controlled placement deed with Acuity Capital for up to $3 million of equity over a 30-month period.
Donaco International Ltd (ASX:DNA) announces that its Managing Director and Chief Executive Officer, Mr Joey Lim, has requested a leave of absence for a period expected to be approximately three months, to deal with health and personal matters.
In accordance with Listing Rule 3.13.3, Donaco International Limited (ASX:DNA) lodges the attached Chairman's address and Managing Director's address, to be delivered at today's Annual General Meeting of shareholders.
